This is a purely administrative share count update with no trading signal. Monitor the next 10-Q for actual financial performance and cash runway, as the company has a $7M market cap and no revenue figures were provided.
Price Chart
Executive Summary
Intelligent Bio Solutions Inc. filed an 8-K solely to update its share count to 3,316,803 as of September 10, 2026, following the exercise of 285,000 prefunded warrants and the issuance of 4,333 restricted shares under a prior advisory agreement. This is a routine administrative disclosure with no financial results, guidance, or material corporate event — it simply confirms the diluted share count for investors.
Key Facts
- Total outstanding shares as of September 10, 2026: 3,316,803
- Increase driven by exercise of 285,000 prefunded warrants and issuance of 4,333 restricted shares
- Restricted shares issued under the February 29, 2024 Investor Relations and Corporate Development Advisory Agreement
- No financial data, guidance, or material business developments reported
Financial Impact
No financial impact disclosed; share count update only
Risk Factors
- No financial performance or guidance disclosed — business fundamentals remain opaque
- Micro-cap with $7M market cap carries inherent liquidity and volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (INBS) — Batch item 1 | 0001493152-26-042411 |
| Document: 0001493152-26-042411-index-headers.html | 0001493152-26-042411 |
| Document: 0001493152-26-042411-index.html | 0001493152-26-042411 |
| Document: 0001493152-26-042411.txt | 0001493152-26-042411 |
| 8-K Filing (INBS) — Batch item 5 | 0001493152-26-042411 |
| Document: 0001493152-26-042411-index-headers.html | 0001493152-26-042411 |
| Document: 0001493152-26-042411-index.html | 0001493152-26-042411 |
| Document: 0001493152-26-042411.txt | 0001493152-26-042411 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 10-K/A | $1.69 | awaiting T+20 | — | $1.67 (−0.89%) |
Oct 13, 2026 13d ago | 8-K | $1.45 | awaiting T+20 | — | $1.67 (+15.17%) |
Sep 24, 2026 4w ago | EFFECT | $1.71 $1.69 | ▲ +1.46% | ▲ +1.04% | $1.67 (+2.34%) |
Sep 15, 2026 5w ago | S-3 | $1.97 $1.48 | ▼ −24.87% | ▼ −28.05% | $1.67 (−15.23%) |
Sep 11, 2026 6w ago | 8-K | $2.07 $1.51 | ▼ −27.05% | ▼ −29.32% | $1.67 (−19.32%) |
Sep 9, 2026 6w ago | 8-K | $2.24 $1.59 | ▼ −29.02% | ▼ −30.96% | $1.67 (−25.45%) |
Sep 2, 2026 7w ago | 8-K | $2.30 $1.66 | ▲ +27.83% | ▲ +26.64% | $1.67 (+27.39%) |
Aug 19, 2026 9w ago | 8-K | $2.67 $2.05 | ▼ −23.22% | ▼ −21.70% | $1.67 (−37.45%) |
Aug 19, 2026 9w ago | Press Release | $2.67 $2.05 | ▲ +23.22% | ▲ +21.70% | $1.67 (+37.45%) |
Aug 17, 2026 10w ago | Press Release | $3.37 $2.05 | ▼ −39.17% | ▼ −37.19% | $1.67 (−50.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers